| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| GFI | GOLD FIELDS LTD | $34.55B | 895,024,247 | 17.51% | 0.01% | Net Buying | Net Buying | ||
| BMEA | BIOMEA FUSION INC | $85.31M | 72,299,440 | 33.68% | 25.19% | Net Buying | |||
| NTHI | NEONC TECHNOLOGIES HOLDINGS INC | $137.09M | 26,013,136 | 11.15% | 73.51% | Net Buying | Net Buying | ||
| PYXS | PYXIS ONCOLOGY INC | $128.61M | 63,355,482 | 43.52% | 37.01% | ||||
| HTHT | H WORLD GROUP LTD | $13.06B | 3,072,694,153 | 4.70% | 0.61% | Net Selling | Net Selling | ||
| GTN | GRAY MEDIA INC | $389.38M | 102,738,455 | 69.47% | 30.53% | Net Buying | Net Selling | ||
| BKD | BROOKDALE SENIOR LIVING INC | $3.26B | 238,789,796 | 45.22% | 54.78% | Net Selling | |||
| CBRS | CEREBRAS SYSTEMS INC | N/A | 212,965,381 | 0.00% | 6.32% | Net Selling | Net Selling | ||
| TECX | TECTONIC THERAPEUTIC INC | $566.45M | 18,869,186 | 26.29% | 73.71% | Net Buying | Net Selling | ||
| KLRS | KALARIS THERAPEUTICS INC | $112.30M | 23,792,278 | 5.85% | 94.15% | Net Buying | Net Buying | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.79B | 47,826,929 | 77.56% | 22.44% | Net Selling | Net Selling | ||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $205.88M | 134,562,917 | 70.06% | 10.89% | Net Buying | |||
| DEFT | DEFI TECHNOLOGIES INC | $216.77M | 387,777,239 | 7.17% | 0.00% | ||||
| RLMD | RELMADA THERAPEUTICS INC | $705.91M | 104,890,223 | 79.76% | 3.37% | Net Buying | |||
| SPRB | SPRUCE BIOSCIENCES INC | $144.11M | 2,752,278 | 3.89% | 96.11% | Net Selling | |||
| ATAI | ATAIBECKLEY INC | $1.49B | 368,166,674 | 27.07% | 32.65% | Net Buying | Net Buying | ||
| VKTX | VIKING THERAPEUTICS INC | $3.53B | 116,105,643 | 63.04% | 8.85% | Net Selling | |||
| MAZE | MAZE THERAPEUTICS INC | $1.42B | 55,345,261 | 88.49% | 11.51% | Net Selling | Net Selling | ||
| WWR | WESTWATER RESOURCES INC | $67.38M | 127,128,703 | 13.37% | 36.15% | Net Selling | Net Selling | ||
| RZLT | REZOLUTE INC | $483.39M | 96,292,331 | 44.44% | 55.56% | Net Buying | Net Buying | ||
| STRO | SUTRO BIOPHARMA INC | $490.98M | 16,570,439 | 48.52% | 51.48% | Net Buying | |||
| TRVI | TREVI THERAPEUTICS INC | $2.44B | 141,979,708 | 43.91% | 56.09% | Net Buying |